Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 334
Selected: 0
NCT IDTitle
NCT02783950Genomics in Michigan Impacting Observation or Radiation
NCT05578898CLEAR Care Companion Application
NCT03927105Nivolumab and the Antagonistic CSF-1R Monoclonal Antibody Cabiralizumab (BMS-986227) in Patients With Relapsed/Refractory Peripheral T Cell Lymphoma
NCT01522937A Study of Individualized Stereotactic Body Radiation Therapy (SBRT) for Intrahepatic Cancer
NCT00151034Trastuzumab (Herceptin), Paclitaxel, Carboplatin and Gemcitabine in Advanced Urothelial Cancer
NCT00176800Chemoradiation and Tetrathiomolybdate (TM) in Patients With Esophageal Carcinoma
NCT00763490Trial Of Double Umbilical Cord Blood Transplantation
NCT01389076Trial of Low-Dose Methotrexate and I 131 Tositumomab for Previously Untreated, Advanced-Stage, Follicular Lymphoma
NCT07532525Pomalidomide After CAR T-cell Therapy for the Treatment of Relapsed or Refractory CD19+ B-cell Leukemia or Lymphoma
NCT03242915Pembrolizumab Plus Chemotherapy in NSCLC With Targetable Genetic Alterations After Progression on Targeted Agents
NCT05653388Metastatic Leiomyosarcoma Biomarker Protocol
NCT07158021Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS Trial
NCT04477200Mycophenolate Mofetil Combined With Radiation Therapy in Glioblastoma
NCT05583422Evaluating a Pharmacogenetic Testing Panel in Patients Suspected to be at Increased Risk for Pharmacogenetics-related AEs While Receiving Fluoropyrimidine or Irinotecan Therapy
NCT00156286Gleevec Maintenance Therapy After Induction Irinotecan and Cisplatin in Patients With C-Kit Positive Extensive SCLC
NCT00955188Computer-Based Tailored or Standard Information for Colorectal Cancer Screening
NCT00644696Study of Irinotecan and Bortezomib in Children With Recurrent/Refractory Neuroblastoma
NCT04827446Lighting Intervention for Cancer-related Fatigue
NCT01794481Benefits of Exercise Training in Head and Neck Cancer Patients Undergoing Organ-Preserving Definitive Therapy
NCT00239200Lapatinib (GW572016) for Metastatic or Recurrent Squamous Cell Carcinoma Esophagus
NCT04852471Improving Quality of Life Using Patient Reported Outcomes Measures Post-operative Via Text Messaging
NCT01973881Quantitative MRI for Myelofibrosis
NCT00320749Capecitabine, Docetaxel and Gemcitabine in Patients With Advanced Pancreas Cancer
NCT07443943A Dietary Supplement (Resistant Potato Starch) for Reducing Musculoskeletal Symptoms in Individuals Planning to Receive Aromatase Inhibitor Therapy, AIMSS-RPS Trial
NCT00115739Trial Evaluating Gleevec in Patients With Anaplastic Thyroid Carcinoma
NCT00242190Gemcitabine, Oxaliplatin and Radiation Therapy in Pancreatic Cancer
NCT04518748Combined Y-90 Selective Internal Radiation Therapy (Y-90 SIRT) and Stereotactic Body Radiation Therapy (SBRT) in Hepatic Malignancy.
NCT06228768Acupressure for Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Patients With Breast Cancer
NCT00637390A Phase I Study of Alemtuzumab in Patients With Relapsed Ovarian/Primary Peritoneal Cancer.
NCT00136487Celecoxib (Celebrex) Versus Placebo in Men With Recurrent Prostate Cancer
NCT00623935Blood Stem Cell Transplantation for the Treatment of Older Patients With Acute Myelogenous Leukemia
NCT01663285Clinical Trial Of Neoadjuvant Chemotherapy (NAC)In Upper Tract Urothelial Carcinoma (UTUC)
NCT00726375The Use of Etanercept Enbrel as Sole Treatment for Grade I Acute Graft Versus Host Disease
NCT01988675MRI Study of Radiation-Induced Damage to White Matter and Blood-Brain-Barrier
NCT00645359Pilot Study of dMRI as a Tool for Early Evaluation of Tumor Response in Diffuse Large B-cell Lymphoma
NCT00616109Sunitinib Maintenance Therapy After Induction Platinum-Based Chemotherapy in Patients With ES-SCLC
NCT00743509A Phase II Study of Oral Cyclophosphamide and Sirolimus (OCR) in Advanced Sarcoma
NCT00064272UMCCOP 02-01 Ginger in Treating Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer
NCT04858256Pacritinib in Relapsed/Refractory T-cell Lymphoproliferative Neoplasms
NCT02729194Pilot Study of Pazopanib With Low Fat Meal (PALM) in Advanced Renal Cell Carcinoma
NCT00726180Use of Trastuzumab to Induce Increased ER Expression in ER-negative/Low, Her-2/Neu Positive Breast Cancer
NCT01814397Pilot Study to Evaluate the Effect of Aromatase Inhibitor Therapy on Pain Threshold in Breast Cancer Patients
NCT00393796Trial of Maintenance SUO11248 Versus Placebo Post Chemotherapy for Patients With Advanced Urothelial Carcinoma
NCT00967824Tamoxifen Citrate Decision Aids for Women at Increased Risk of Breast Cancer
NCT02031250Randomized Phase II Study of DCE-MRI-based Dose Escalation for Poor-prognosis and Neck Cancer
NCT00603057Using Imaging and Molecular Markers to Predict Tumor Response and Lung Toxicity in Lung Cancer
NCT03287063Study Using Genomic, Histologic and Radiomic Analysis to Evaluate Regional Tumor Heterogeneity in Patients Undergoing Surgery for Newly Diagnosed Glioblastoma
NCT05038332Post-prostatectomy Radiation Therapy--Moderate Versus Ultra-hypofractionated (Also Known as Stereotactic Body Radiation Therapy [SBRT])
NCT03639935Rucaparib in Combination With Nivolumab in Patients With Advanced or Metastatic Biliary Tract Cancer Following Platinum Therapy
NCT00151073Estramustine, Docetaxel and Zoledronate Treatment in Hormone-Refractory Adenocarcinoma of the Prostate